Pancreatic Cancer Research

ResearcherVirginia Commonwealth UniversityNo recent work listed

Andrew Stewart Poklepovic

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0002-4015-5037; OpenAlex author ID A5080982053.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2
Pancreatic cancer trials
2 (principal investigator on 2)
Pancreatic cancer grants
0
Collaborators
3
Papers, trials and grants by year

2015: 1 trial · 2016: none · 2017: none · 2018: none · 2019: 1 trial · 2020: 1 paper · 2021: 1 paper

Papers 2

  1. The development of multi-kinase inhibitors as pancreatic cancer therapeutics. Co-author DOI 10.1097/cad.0000000000001177↗
  2. Neratinib decreases pro-survival responses of [sorafenib + vorinostat] in pancreatic cancer. Co-author DOI 10.1016/j.bcp.2020.114067↗

Trials 2

  1. Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca Principal investigator NCT03919292↗
  2. Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Cancer Principal investigator NCT02349867↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Paul Dent · 2 shared papers, 2020–2021
  2. Laurence A. Booth · 2 shared papers, 2020–2021
  3. John F. Hancock · 1 shared paper, 2021

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.